Vaxxinity Inc's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vaxxinity Inc's ROI in the fourth quarter of 2023?
Vaxxinity Inc recorded a cumulative net loss of $-57 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on investment (ROI) of -134.54%.

Within the Healthcare sector 897 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2023 from 0 to 5257.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Investment Change TTM	-57.34 %	-52.66 %	-40.82 %	-1.81 %	83.89 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	27	36	48	59	75
Return On Investment (TTM)	-134.54 %	-121.08 %	-105.79 %	-90.61 %	-75.83 %
VAXX's Overall Ranking	# 5257	# 0	# 4108	# 4026	# 4610
Seq. Investment Change TTM	-22.36 %	-20.03 %	-18.07 %	-16.14 %	-13.84 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-57	-66	-72	-75	-75

VAXX Company Profile >> Back to VAXX Roi Comparisons >> See Annual VAXX Return On Investment

Return On Investment VAXX's Ranking
Within:	No.
Industry	# 425
Sector	# 898
Overall	# 5257

Return On Investment Statistics
High	Average	Low
-75.83 %	-113.94 %	-145.66 %
(Dec 31 2022)		(Jun 30 2022)

Financial Statements
Vaxxinity Inc's IV. Quarter Investments	$ 27 Millions	VAXX's Balance sheet
Vaxxinity Inc's IV. Quarter Income	$ -11 Millions	Quarterly VAXX's Income Statement
VAXX's Income by Division		See VAXX's Income by Division

VAXX Annual Return On Investment	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	27	75	139	0	0
Y / Y Investment Growth	-64.61 %	-45.78 %	-	-	-
Net Income in Millions	-57	-75	-137	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-213.19 %	-99.69 %	-98.56 %	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VAXX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VAXX's Competitors
Subscribers only: Roi for Vaxxinity Inc's Suppliers
Subscribers only: Return On Investment for VAXX's Customers

Other Ratios
VAXX's Roa	VAXX's Inventory Turnover Ratio	VAXX's Growth Rates	VAXX's Dividend Statistics
	VAXX's Profitability Ratios	VAXX's Asset Turnover Ratio	VAXX's Dividend Growth
VAXX's Roe	VAXX's Valuation Ratios	VAXX's Financial Strength Ratios	VAXX's Dividend Payout Ratio

Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector

ROI

Date modified: 2026-09-08T15:11:13+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.